
A smartwatch may be able to replace a sleep diary to evaluate falling asleep and waking times for those with insomnia.
A smartwatch may be able to replace a sleep diary to evaluate falling asleep and waking times for those with insomnia.
Physically active individuals who had fewer than 6 hours of sleep showed faster cognitive decline overall.
The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.
The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.
Employees who did frequently use AI systems were more than likely to offer help to fellow employees, though it could have been a response to their loneliness.
Current social determinants of health found to have a significant impact on sleep health.
Clinicians are increasingly recognizing the negative impact of the middle-of-the-night dosing required with twice-nightly therapies for narcolepsy.
People with less severe symptoms of insomnia still had a 16% increased risk of stroke compared to people with no symptoms.
Having more severe sleep apneas was associated with having lower brain volume in the medial temporal lobe area of the brain, which could suggest loss of brain cells.
The sleep hormone decreased intestinal homeostasis, which may augment inflammation that causes tissue and intestinal damage.
There are common symptoms experienced in the workplace that may be linked to hormones instead of stress.
A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.
The final approval was based on efficacy and safety data from the phase 3 REST-ON study.
A higher carbohydrate diet was linked to earlier sleep and wake times, despite low carbohydrate consumption among study participants.
Poor sleep efficiency may contribute to vascular dysfunction with increasing exposure to adverse childhood experiences.
The number of female study participants was lower when the last author of the study, usually the head of the lab conducting the study, was a man.
Pharmacists are uniquely positioned to interact with patients who may be seeking an OTC drug or supplement as first-line therapy for short sleep duration.
41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.
For chronic cases, encourage patients to seek medical care from their primary health care providers.
It is still unclear whether comorbidities have similar negative effects on cognition beyond those directly caused by obstructive sleep apnea.
Investigators suggest that sleep interventions may help to reduce the risk of self-harm in female adolescents with depression and anxiety.
Sodium oxybate is currently being studied for long-term safety and tolerability in the open label RESTORE clinical study in adults with narcolepsy.
More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.
Pharmacists should be vigilant in recognizing medications that are causing insomnia in a patient's profile or electronic medical record.
The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.